Idexx Laboratories (IDXX) Operating Leases (2019 - 2026)

Idexx Laboratories' Operating Leases history runs 8 years deep, the most recent figure standing at $125.6 million for Q1 2026.

• In Q1 2026, Operating Leases rose 29.48% year-over-year to $125.6 million; the TTM figure through Mar 2026 stood at $125.6 million (up 29.48% YoY), while the FY2025 annual figure was $101.2 million, up 3.39% from the prior year.
• Operating Leases for Q1 2026 stood at $125.6 million, up from $101.2 million in the prior quarter.
• The five-year high for Operating Leases was $133.1 million in Q3 2025, with the low at $89.6 million in Q1 2022.
• The 5-year median for Operating Leases is $103.0 million (2024), against an average of $107.7 million.
• The sharpest annual moves came in 2023 and 2024: Operating Leases soared 30.96% in 2023, then fell 11.5% in 2024.
• Idexx Laboratories' Operating Leases stood at $101.2 million in 2022, then fell by 1.55% to $99.7 million in 2023, then dropped by 1.84% to $97.8 million in 2024, then advanced by 3.39% to $101.2 million in 2025, then advanced by 24.17% to $125.6 million in 2026.
• Business Quant data shows IDXX's Operating Leases at $125.6 million in Q1 2026, $101.2 million in Q4 2025, and $133.1 million in Q3 2025.